High Stress-Induced Blood Sugar Linked to Increased ARDS and Mortality in Sepsis Patients: Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-10-09 15:30 GMT   |   Update On 2025-10-09 15:31 GMT
Advertisement

China: Researchers have found that a higher stress hyperglycemia ratio (SHR) is strongly associated with an increased risk of acute respiratory distress syndrome (ARDS) and in-hospital mortality among patients with sepsis.

The study, published in Scientific Reports, analyzed data from 1,946 sepsis patients and highlighted that individuals in the highest SHR quartile faced a 42% higher risk of developing ARDS and a 40% greater risk of dying during hospitalization compared with those in the lowest quartile.
Advertisement
The study, led by Xianwei Jin and colleagues from the Department of Medicine, Graduate School, Nanchang University, China, aimed to investigate the relationship between SHR—a measure comparing acute blood glucose elevation to baseline glycemic status—and ARDS risk in sepsis patients. Data were sourced from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, a comprehensive repository of intensive care unit patient records in the United States.
Patients were stratified into four groups based on SHR quartiles. The primary outcome assessed was the occurrence of in-hospital ARDS. Researchers employed multivariate Cox proportional-hazards regression and restricted cubic spline models to examine the correlation between SHR and ARDS risk. Subgroup analyses and Kaplan-Meier survival curves further supported the findings.
The study led to the following notable findings:
  • 34% of participants developed acute respiratory distress syndrome (ARDS).
  • 13% of participants died during hospitalization.
  • The stress hyperglycemia ratio (SHR) was independently associated with both ARDS and in-hospital mortality after adjusting for confounders.
  • Risk of ARDS and mortality increased approximately linearly with rising SHR levels, especially for mild and moderate ARDS.
  • Subgroup analyses showed that the association between SHR and adverse outcomes was consistent across different patient populations.
According to the researchers, these findings suggest that SHR can serve as a valuable early indicator for identifying patients with sepsis at high risk of ARDS, potentially enabling timely interventions and improved clinical management. The study emphasizes the clinical relevance of monitoring stress-induced hyperglycemia as part of comprehensive sepsis care.
The study had some limitations: it included only U.S. patients, mostly White, limiting generalizability; its retrospective, observational design precludes causal conclusions; and as a single-center study with a modest sample size, residual confounding may still affect the results.
The authors recommend that prospective, multicenter studies be conducted to validate these results and further explore the mechanistic links between SHR and ARDS.
"Elevated SHR is significantly linked to higher in-hospital mortality and ARDS risk in patients with sepsis. Monitoring SHR could help clinicians identify high-risk individuals early, enabling better risk stratification and guiding timely interventions. Future prospective studies are necessary to confirm these findings and inform clinical strategies for managing stress hyperglycemia in sepsis patients," the authors concluded.
Reference:
Jin, X., Deng, W., Weng, Q., Liu, F., & Min, J. (2025). Correlation between stress hyperglycemia ratio and risk of acute respiratory distress syndrome in patients with sepsis: A MIMIC-IV cohort study. Scientific Reports, 15(1), 1-13. https://doi.org/10.1038/s41598-025-18349-4
Tags:    
Article Source : Scientific Reports

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News